Clinical Trial Update: Phase 2a, 28-day Investigational Use Study of ARINA-1 in Non-Cystic Fibrosis Bronchiectasis (NCFBE) With Excess Mucus and Cough [Phase 2]

View source ↗

Summary

ARINA-1 was evaluated in a 28-day Phase 2a investigational-use trial for non-cystic fibrosis bronchiectasis with excess mucus and cough, and the study has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-cystic Fibrosis Bronchiectasis

Drugs mentioned

• ARINA-1

Snippet

Sponsor: Renovion, Inc. | Conditions: Non-cystic Fibrosis Bronchiectasis | Phase 2 | Status: COMPLETED